Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
life sciences
3
×
national blog main
san diego blog main
3
×
san diego top stories
biotech
clinical trials
drugs
new york blog main
san diego
achaogen
adams street partners
akcea therapeutics
antibiotics
anylam pharmaceuticals
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
boston blog main
boston top stories
california life sciences association (clsa)
cardiomyopathy
deals
drug resistance
fda
hatteras venture partners
inotersen
investing
lyzz capital
macrolide pharmaceuticals
melinta therapeutics
meropenem
michael dudley
mike guerra
national top stories
neuropathy
new enterprise associates
new york
new york top stories
onpattro
patisiran
pfizer
What
disease
3
×
medicines
3
×
drug
year
ago
akcea
alnylam
amyloidosis
approved
attr
available
bacteria
battle
better
biopharma
business
california
clinicians
community
companies
company
debilitating
devices
diagnostics
education
established
exited
fda
fight
fighting
fueled
genetic
giving
infections
infectious
launches
life
melinta
new
oks
Language
Current search:
medicines
×
photo
×
" life sciences "
×
disease
×
" san diego blog main "
×
@xconomy.com
5 years ago
California Life Sciences Fueled by Education, Established Companies
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections